Abiopharma

🔍 Ferre Maria Luisa (Executive)

Company: POPULAR, INC. (BPOP)

Report Date: 2026-07-30

Detailed Transactions and Holdings:

• Sold 3,076 shares of Common Stock Par Value $0.01 per share at $173.786 per share (Direct)
  Date: 2026-07-30 | Code: S | equity_swap_involved: false | shares_owned_after: 34,400.96 | transaction_form_type: 4 | Footnotes: F1
• Sold 3,385 shares of Common Stock Par Value $0.01 per share at $175.42 per share (Direct)
  Date: 2026-07-30 | Code: S | equity_swap_involved: false | shares_owned_after: 10,156.00 | transaction_form_type: 4 | Footnotes: F2
• Holds 17,494 shares of Restricted Stock Units (Derivative)
  Date: 2026-07-30 | Code: H | shares_owned_after: 17,494.00 | Footnotes: F3, F4, F4

Footnotes:

• F1: This price is a weighted average price. These shares were sold in multiple transactions ranging from $173.70 and $173.835, inclusive. The reporting person undertakes to provide the Corporation, any security holder of the Corporation, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in this footnote.
• F2: Ms. Ferre is the President and a Trustee of the Luis A Ferre Foundation, Inc.
• F3: Restricted stock units convert into common stock on a one-for-one basis.
• F4: Restricted stock units are converted into an equivalent number of shares of common stock and issued to the reporting person on the 15th of August following the date of termination of service as a director.